Company: MVIS
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001641172-25-006436
Chunk: 62

Company: MICROVISION, INC.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 62
---
 Verma   |     | 06/04/2024 (5)                    |     | 06/04/2024                                                    |     |                    |   200,000 |     | $             |   220,000 |
|                 |     | 06/04/2024 (4)                    |     | 06/04/2024                                                    |     |                    |   450,000 |     | $             |   495,000 |
|                 |     | 06/04/2024 (6)                    |     | 06/04/2024                                                    |     |                    |   200,000 |     | $             |   204,875 |
| Drew G. Markham |     | 06/04/2024 (5)                    |     | 06/04/2024                                                    |     |                    |   186,250 |     | $             |   204,875 |
|                 |     | 06/04/2024 (4)                    |     | 06/04/2024                                                    |     |                    |   360,000 |     | $             |   396,000 |
|                 |     | 06/04/2024 (6)                    |     | 06/04/2024                                                    |     |                    |   186,250 |     | $             |   220,000 |

| (1) | The number of shares reported in this column represent RSUs granted under our 2022 Equity Incentive Plan, and for some awards pursuant to an employment agreement for Mr. Sharma and/or our 2024 Executive Bonus Plan, and which are described in more detail in the Compensation Discussion and Analysis and the notes below. |

| 39 |

| (2) | The dollar amounts reported in this column reflect the aggregate grant date fair value, excluding the effect of estimated forfeitures, of the awards granted in the most recently completed fiscal year pursuant to our 2022 Equity Incentive Plan, determined in accordance with financial accounting rules (FASB ASC Topic 718) rather than an amount paid to or realized by the executive officer. For a discussion of valuation assumptions for these awards, see Note 9 to our Notes to Financial Statements included in our annual report on Form 10-K for the most recently completed fiscal year. As described in Note 9, the grant date fair value is based on the closing price of our common